Inovio Pharmaceuticals Closes $24.3 Million Registered Offering

Published January 30, 2011

Inovio Pharmaceuticals Closes .3 Million Registered Offering
BLUE BELL, Pa., Jan. 27, 2011 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the closing of the sale to a single institutional investor of 21,130,400 shares of its common stock and warrants to purchase up to 10,565,200 additional shares of its common stock …
Read more on redOrbit

Edwin Moses wins career fair play award
By Paul Radford
Read more on Reuters via Yahoo! Singapore News

Edwin Moses wins career fair play award
By Paul Radford
Read more on Reuters via Yahoo! Philippines News